We also explored differences in AP4M1 expression among different AFP expression, suggesting that AP4M1 is able to identify changes in AFP levels and may be used as a candidate biomarker for early diagnosis of HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.